Cachexia and aging: an update based on the Fourth International Cachexia Meeting.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.Age and ageing · 2010
   Guideline
2. A trial assessing N-3 as treatment for injury-induced cachexia (ATLANTIC trial): does a moderate dose fish oil intervention improve outcomes in older adults recovering from hip fracture?BMC geriatrics · 2010
   Trial
3. Hallmarks of Cancer Cachexia: Sexual Dimorphism in Related Pathways.International journal of molecular sciences · 2025
   Review
4. Oxidant-Based Cytotoxic Agents During Aging: From Disturbed Energy Metabolism to Chronic Inflammation and Disease Progression.Biomolecules · 2025
   Review
5. Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review.Biomedicines · 2023
   Review
6. Relationship between sarcopenia and cachexia with prognostic markers of middle-aged and older inpatients with COVID-19: a case-control study.European geriatric medicine · 2023
   Article
7. Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX).Nutrients · 2022
   Observational
8. Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation.Frontiers in nutrition · 2022
   Review
9. The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects.Frontiers in cell and developmental biology · 2021
   Review
10. COVID-19: a major cause of cachexia and sarcopenia?Journal of cachexia, sarcopenia and muscle · 2020
    Article
11. Pathogenesis and Management of Sarcopenia.Clinics in geriatric medicine · 2017
    Review
12. Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition.Oncotarget · 2015
    Review
13. Are we closer to having drugs to treat muscle wasting disease?Journal of cachexia, sarcopenia and muscle · 2014
    Article
14. The role of vitamin D in skeletal and cardiac muscle function.Frontiers in physiology · 2014
    Article
15. Anorexia of aging: a modifiable risk factor for frailty.Nutrients · 2013
    Review
16. Development and relative validity of a new field instrument for detection of geriatric cachexia: preliminary analysis in hip fracture patients.Journal of cachexia, sarcopenia and muscle · 2013
    Article
17. Anorexia of aging: a true geriatric syndrome.The journal of nutrition, health & aging · 2012
    Article
18. Effects of anorexia on mortality among older adults receiving home care: an observation study.The journal of nutrition, health & aging · 2012
    Article
19. Senile anorexia in different geriatric settings in Italy.The journal of nutrition, health & aging · 2011
    Article
20. Frailty: diagnosis and management.The journal of nutrition, health & aging · 2011
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as